Global Acute Respiratory Distress Syndrome Market Overview
According to Renub Research global Acute Respiratory Distress Syndrome (ARDS) market is experiencing strong growth driven by rising prevalence of critical respiratory illnesses, advancements in treatment technology, and expanding research activities. The market was valued at US$ 1.32 billion in 2024 and is projected to reach US$ 2.53...